Literature DB >> 29676489

Improving the echocardiographic assessment of pulmonary pressure using the tricuspid regurgitant signal-The "chin" vs the "beard".

Stephen J Kyranis1,2, Jilani Latona1,2, David Platts1,2,3, Natalie Kelly1,2, Michael Savage1,2, Martin Brown2,3, Christian Hamilton-Craig1,2,4,5, Gregory M Scalia1,2, Darryl Burstow1,2.   

Abstract

AIM: Transthoracic echocardiography (TTE) is a fundamental investigation for the noninvasive assessment of pulmonary hemodynamics and right heart function. The aim of this study was to assess the correlation and agreement of Doppler calculation of right ventricular systolic pressure (RVSP) and pulmonary vascular resistance (PVR) using "chin" and "beard" measurements of tricuspid regurgitant velocity (TRVmax ), with invasive pulmonary artery systolic pressure (PASP) and PVR.
METHODS: One hundred patients undergoing right heart catheterisation (RHC) and near simultaneous transthoracic echocardiography were studied. TRVmax was recorded for "chin" measurement (distinct peak TRVmax signal) and where available (63 patients), "beard" measurement (higher indistinct peak TRVmax signal).
RESULTS: Measurable TRV signal was obtained in 96 patients. Mean RVSPchin 54.7 ± 22.7 mm Hg and RVSPbeard 68.6 = 23 ± 26.3 mm Hg (P < .001). There was strong correlation between both RVSPchin and RVSPbeard with invasive PASP (Pearson's r = .9, R2  = 0.82, P < .001 - r = .88, R = .78, P < .001, respectively.). Bland-Altman analysis for RVSPchin and RVSPbeard showed a mean bias of -0.5 mm Hg (95% limits of agreement -21.4 to 20.5 mm Hg) and -10.7 (95% LOA -35.5 to 14.2 mm Hg), respectively. Receiver operator characteristics of TRVmax "chin" and "beard" for diagnosis of pulmonary hypertension was assessed with optimal cut-offs being 2.8 m/s (sensitivity 93%, specificity 87%) and 3.2 m/s (sensitivity 91%, specificity 82%), respectively. There was similar correlation between PVRchin and PVRbeard (r = .87, R2  = 0.75, P < .001 and r = .86, R2  = 0.74, P < .001, respectively). At higher PVR, there was overestimation of calculated PVR using PVRbeard .
CONCLUSION: The accuracy of noninvasive measurement of right heart pressures is increased using the "chin" in estimation of both RVSP and PVR.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  TRV; echocardiography; pulmonary hypertension; tricuspid regurgitant velocity

Mesh:

Year:  2018        PMID: 29676489     DOI: 10.1111/echo.13893

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.

Authors:  Yasushi Tsujimoto; Junji Kumasawa; Sayaka Shimizu; Yoshio Nakano; Yuki Kataoka; Hiraku Tsujimoto; Michihiko Kono; Shinji Okabayashi; Haruki Imura; Takahiro Mizuta
Journal:  Cochrane Database Syst Rev       Date:  2022-05-09

2.  Survival characteristics and prognostic importance of echocardiographic measurements of right heart size and function in dogs with pulmonary hypertension.

Authors:  Lance C Visser; James E Wood; Lynelle R Johnson
Journal:  J Vet Intern Med       Date:  2020-06-05       Impact factor: 3.333

3.  Elucidating tricuspid Doppler signal interpolation and its implication for assessing pulmonary hypertension.

Authors:  Seraina A Dual; Constance Verdonk; Myriam Amsallem; Jonathan Pham; Courtney Obasohan; Patrick Nataf; Doff B McElhinney; Alisa Arunamata; Tatiana Kuznetsova; Roham Zamanian; Jeffrey A Feinstein; Alison Marsden; François Haddad
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

4.  ACVIM consensus statement guidelines for the diagnosis, classification, treatment, and monitoring of pulmonary hypertension in dogs.

Authors:  Carol Reinero; Lance C Visser; Heidi B Kellihan; Isabelle Masseau; Elizabeth Rozanski; Cécile Clercx; Kurt Williams; Jonathan Abbott; Michele Borgarelli; Brian A Scansen
Journal:  J Vet Intern Med       Date:  2020-02-17       Impact factor: 3.333

5.  Echocardiographic estimate of pulmonary artery pressure in sarcoidosis patients - real world data from a multi-national study.

Authors:  Marloes P Huitema; Marco C Post; Jan C Grutters; Athol U Wells; Vasilis Kouranos; Oksana A Shlobin; Steven D Nathan; Daniel A Culver; Joseph Barney; Rohit Gupta; Eva Carmona; Esam H Alhamad; Mary B Scholand; Marlies Wijsenbeek; Sivagini Ganesh; Elyse E Lower; Peter J Engel; Robert P Baughman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-01-13       Impact factor: 1.803

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.